Answers are grounded in this paper and cite their sources.
We demonstrate that LMSCs are less sensitive to senescence induction by oxidative stress and replication than LFs, which was accompanied by an increased ability to expand. This makes LMSCs more suitable for cell-based therapies in COPD. As senescence affected growth factors involved in alveolar repair, specifically FGF10 expression in both LMSCs and LFs, we additionally suggest that the development of anti-senescence strategies may promote endogenous tissue repair in COPD.
No takes yet. Share an insight, caveat, or question.
Wisman et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: